Gene · 6614
Papers2,964
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,964
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative bulk and single-cell transcriptomics link EZH2 to immunosuppressive programs and tumor-Treg crosstalk in castration-resistant prostate cancer. | Front Immunol | 2026 | 41710887 | PubTator, text mining | PubMed |
| The immunopathological crosstalk of diabetic periodontitis: Single-cell insights into monocyte dysregulation. | PLoS One | 2026 | 41701724 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages in cancer development and their significance as prognostic markers. | Clin Exp Med | 2026 | 41697492 | PubTator, text mining | PubMed |
| SIGLEC-1 Expression in a Cohort of Patients With Lupus Erythematosus Treated With Anifrolumab. | JAMA Dermatol | 2026 | 41671013 | PubTator, text mining | PubMed |
| Anatomy of the intralobular and interlobular lymphatics in the human lung with special references to its topographical relation to lymph nodules and nodular composite cells. | Ann Anat | 2026 | 41651298 | PubTator, text mining | PubMed |
| CD169 expression of CD14+ monocyte as a biomarker in the early infection of HIV-1. | BMC Infect Dis | 2026 | 41639637 | PubTator, text mining | PubMed |
| Clinically validated assay for rapid determination of type I and type II interferon activity in systemic inflammatory diseases. | J Allergy Clin Immunol | 2026 | 41638262 | PubTator, text mining | PubMed |
| Type I Interferon Gene Expression and Its Association With Ocular Involvement in Systemic Lupus Erythematosus. | ACR Open Rheumatol | 2026 | 41614297 | PubTator, text mining | PubMed |
| Metastatic organotropism in peritoneal metastasis: Paget's hypothesis revisited. | Clin Exp Med | 2026 | 41609906 | PubTator, text mining | PubMed |
| Detailed Splenic Single-Cell Biodistribution of Phosphatidylglycerol-Containing Liposomes. | Mol Pharm | 2026 | 41605494 | PubTator, text mining | PubMed |
| Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank. | Nat Commun | 2026 | 41593088 | PubTator, text mining | PubMed |
| Elevated type I interferon signature in patients with chronic granulomatous disease. | Clin Exp Immunol | 2026 | 41559882 | PubTator, text mining | PubMed |
| Beyond the surface: soluble SIGLEC-1 as a clinically applicable type I IFN biomarker. | Rheumatology (Oxford) | 2026 | 41548235 | PubTator, text mining | PubMed |
| Proteotranscriptomic Dissection of Breast Cancer T Cell States Identifies CD103+ Tfh-derived Cytotoxic Cells Linked to Immunotherapy Response. | Res Sq | 2026 | 41542042 | PubTator, text mining | PubMed |
| The Role of Iron-Overloaded Macrophages in Mesenchymal Stem Cell Senescence and Anemia in Myelodysplastic Syndromes: Protocol for an In Vitro Study. | JMIR Res Protoc | 2026 | 41529258 | PubTator, text mining | PubMed |
| ACE2-independent entry factors for SARS-CoV-2 infection and immune activation. | mBio | 2026 | 41427721 | PubTator, text mining | PubMed |
| Autoantibodies against type I interferons correlate with low CD169/SIGLEC1 and severe non-viral infections in ER patients. | Clin Exp Immunol | 2026 | 41329209 | PubTator, text mining | PubMed |
| CD169+ Macrophage-Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication. | Adv Sci (Weinh) | 2026 | 41243224 | PubTator, text mining | PubMed |
| Siglec-1+ macrophages in anti-tumor immunity. | Immunol Lett | 2026 | 41205710 | PubTator, text mining | PubMed |
| The diagnostic performance of a novel flow cytometry-based assay for the diagnosis of systemic lupus erythematosus. | Clin Chim Acta | 2026 | 41093129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6614/papers?page=5